Literature DB >> 29233703

The risk of osteonecrosis on alveolar healing after tooth extraction and systemic administration of antiresorptive drugs in rodents: a systematic review.

Victor Lousan do Nascimento Poubel1, Carolina Amália Barcellos Silva2, Luis André Mendonça Mezzomo3, Graziela De Luca Canto3, Elena Riet Correa Rivero4.   

Abstract

PURPOSE: There is much concern about the increasing number of patients with medication-related osteonecrosis of the jaw (MRONJ), and many studies have been published in an attempt to understand the pathophysiology of this condition. This study aimed to systematically review the literature on MRONJ arising in rodents under antiresorptive drug therapy after tooth extraction.
METHODS: A search of electronic databases, including LILACS, PROQUEST, PubMed, SCOPUS, and the Web of Science.
RESULTS: The search resulted in 2319 titles after removing the duplicates, and one paper was identified using the reference list. Ninety-eight full-text papers were then screened for eligibility, resulting in 20 for inclusion in the final qualitative synthesis. The quality of the articles was assessed using the 'ARRIVE' tool.
CONCLUSION: Despite the wide heterogeneity of the methodologies used by the authors, the current available evidence suggests that the combination of bisphosphonate and/or denosumab therapy and tooth extraction is associated with osteonecrosis of the jaw in rodents.
Copyright © 2017 European Association for Cranio-Maxillo-Facial Surgery. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Animal; Bisphosphonates; Denosumab; Rodents; Systematic review

Mesh:

Substances:

Year:  2017        PMID: 29233703     DOI: 10.1016/j.jcms.2017.11.008

Source DB:  PubMed          Journal:  J Craniomaxillofac Surg        ISSN: 1010-5182            Impact factor:   2.078


  7 in total

Review 1.  Skeletal changes during and after spaceflight.

Authors:  Laurence Vico; Alan Hargens
Journal:  Nat Rev Rheumatol       Date:  2018-03-21       Impact factor: 20.543

Review 2.  Osteonecrosis of the Jaw and Antiresorptive Agents in Benign and Malignant Diseases: A Critical Review Organized by the ECTS.

Authors:  Athanasios D Anastasilakis; Jessica Pepe; Nicola Napoli; Andrea Palermo; Christos Magopoulos; Aliya A Khan; M Carola Zillikens; Jean-Jacques Body
Journal:  J Clin Endocrinol Metab       Date:  2022-04-19       Impact factor: 6.134

3.  Antiresorptive medication in oncology: the clinical and dental profile of patients in a reference center.

Authors:  Vitor Hugo Candido Ferreira; Aristilia Tahara Kemp; Joana Vendruscolo; Laurindo Moacir Sassi; Juliana Lucena Schussel
Journal:  J Korean Assoc Oral Maxillofac Surg       Date:  2021-02-28

4.  Biodegradable magnesium implant enhances angiogenesis and alleviates medication-related osteonecrosis of the jaw in rats.

Authors:  Wang-Yong Zhu; Jiaxin Guo; Wei-Fa Yang; Zhuo-Ying Tao; Xinmiao Lan; Leilei Wang; Jiankun Xu; Ling Qin; Yu-Xiong Su
Journal:  J Orthop Translat       Date:  2022-03-28       Impact factor: 5.191

Review 5.  Establishment and assessment of rodent models of medication-related osteonecrosis of the jaw (MRONJ).

Authors:  Ran Yan; Ruixue Jiang; Longwei Hu; Yuwei Deng; Jin Wen; Xinquan Jiang
Journal:  Int J Oral Sci       Date:  2022-08-10       Impact factor: 24.897

6.  Beta tricalcium phosphate, either alone or in combination with antimicrobial photodynamic therapy or doxycycline, prevents medication-related osteonecrosis of the jaw.

Authors:  Henrique Hadad; Laís Kawamata de Jesus; Ana Flávia Piquera Santos; Henrique Rinaldi Matheus; Letícia Gabriella de Souza Rodrigues; Pier Paolo Poli; Elcio Marcantonio Junior; Fernando Pozzi Semeghini Guastaldi; Carlo Maiorana; Juliano Milanezi de Almeida; Roberta Okamoto; Francisley Ávila Souza
Journal:  Sci Rep       Date:  2022-10-03       Impact factor: 4.996

Review 7.  Dental care for patients taking antiresorptive drugs: a literature review.

Authors:  Minju Song
Journal:  Restor Dent Endod       Date:  2019-11-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.